StonvexLoading…
StonvexStonvexStonvexCore line items from AMX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $42.89B | $48.30B | $43.50B | $41.56B |
Operating Income | $8.89B | $9.93B | $8.80B | $8.07B |
Net Income | $1.36B | $4.78B | $4.20B | $9.54B |
EPS (Diluted) | $0.02 | $1.21 | $1.30 | $1.03 |
Total Assets | $88.51B | $92.59B | $83.35B | $82.09B |
Total Liabilities | $67.19B | $67.63B | $60.79B | $60.03B |
Cash & Equivalents | $1.81B | $1.31B | $2.00B | $1.99B |
Free Cash Flow OCF − CapEx | $6.23B | $6.93B | $4.08B | $5.49B |
Shares Outstanding | Not available | 62.45B | 63.33B | 64.69B |